YTHDF2 and hepatocellular carcinoma: Conversely, YTHDF2 overexpression inhibits HCC cell growth and proliferation by binding directly to the m6A modification site on the 3′-UTR of EGFR mRNA, promoting its degradation and halting tumor progression (Zhong et al., 2019).